In an innovative move ahead of the flu season, AstraZeneca has announced the launch of its at-home delivery service for the FluMist nasal spray, the only nasal spray flu vaccine approved in the nation. This service allows individuals to receive their flu vaccine directly to their doorstep, making it easier for people to get vaccinated as vaccination rates decline. The self-administrable FluMist can now be given at home, offering a convenient option for those looking to protect themselves from the flu.